Loomis Sayles & Co. L P Has $6.98 Million Holdings in Select Medical Holdings Co. (NYSE:SEM)

Loomis Sayles & Co. L P lifted its stake in Select Medical Holdings Co. (NYSE:SEM - Free Report) by 33.0% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 370,425 shares of the health services provider's stock after buying an additional 91,956 shares during the period. Loomis Sayles & Co. L P owned approximately 0.29% of Select Medical worth $6,983,000 as of its most recent SEC filing.

A number of other large investors have also modified their holdings of the stock. JPMorgan Chase & Co. raised its position in shares of Select Medical by 18.3% in the 4th quarter. JPMorgan Chase & Co. now owns 492,383 shares of the health services provider's stock valued at $9,281,000 after purchasing an additional 76,084 shares in the last quarter. EntryPoint Capital LLC bought a new position in Select Medical in the fourth quarter worth about $453,000. Segall Bryant & Hamill LLC boosted its position in Select Medical by 7.3% during the 4th quarter. Segall Bryant & Hamill LLC now owns 85,099 shares of the health services provider's stock valued at $1,604,000 after purchasing an additional 5,756 shares during the period. Prudential Financial Inc. boosted its holdings in shares of Select Medical by 2.4% during the fourth quarter. Prudential Financial Inc. now owns 111,920 shares of the health services provider's stock valued at $2,110,000 after acquiring an additional 2,582 shares during the period. Finally, Vanguard Group Inc. grew its position in shares of Select Medical by 1.0% during the fourth quarter. Vanguard Group Inc. now owns 12,712,990 shares of the health services provider's stock worth $239,640,000 after acquiring an additional 131,228 shares during the last quarter. Institutional investors and hedge funds own 89.48% of the company's stock.

Remove Ads

Select Medical Trading Down 4.1 %

Shares of NYSE:SEM traded down $0.69 during midday trading on Thursday, reaching $15.99. The company had a trading volume of 150,012 shares, compared to its average volume of 792,815. The company has a fifty day simple moving average of $18.22 and a two-hundred day simple moving average of $24.64. The firm has a market cap of $2.06 billion, a price-to-earnings ratio of 9.69, a price-to-earnings-growth ratio of 0.64 and a beta of 1.56. Select Medical Holdings Co. has a 1-year low of $15.92 and a 1-year high of $40.98. The company has a debt-to-equity ratio of 1.37, a quick ratio of 1.13 and a current ratio of 1.13.

Select Medical (NYSE:SEM - Get Free Report) last released its quarterly earnings results on Thursday, February 20th. The health services provider reported $0.18 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.29 by ($0.11). Select Medical had a net margin of 3.23% and a return on equity of 14.04%. The firm had revenue of $1.31 billion for the quarter, compared to analyst estimates of $1.50 billion. Research analysts predict that Select Medical Holdings Co. will post 1.17 earnings per share for the current year.

Select Medical Cuts Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, March 13th. Shareholders of record on Monday, March 3rd were paid a dividend of $0.0625 per share. The ex-dividend date was Monday, March 3rd. This represents a $0.25 annualized dividend and a yield of 1.56%. Select Medical's dividend payout ratio (DPR) is presently 15.15%.

Analyst Ratings Changes

Several research firms have commented on SEM. Benchmark upgraded shares of Select Medical from a "hold" rating to a "buy" rating and set a $23.00 target price for the company in a research report on Monday, February 24th. UBS Group cut their target price on Select Medical from $40.00 to $21.00 and set a "neutral" rating on the stock in a research note on Friday, January 3rd. StockNews.com raised Select Medical from a "hold" rating to a "buy" rating in a report on Friday, February 21st. Finally, Royal Bank of Canada reduced their price objective on shares of Select Medical from $47.00 to $23.00 and set an "outperform" rating for the company in a report on Monday, February 24th. One research analyst has rated the stock with a hold rating and four have issued a buy rating to the stock. According to MarketBeat, Select Medical currently has an average rating of "Moderate Buy" and a consensus price target of $27.25.

Select Medical Company Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.